Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Tesfamariam

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
Influence of the endothelium on tone and the response of isolated pig coronary artery to norepinephrineR A Cohen, K M Zitnay, R M Weisbrod, et al.
Journal of Cardiovascular Pharmacology|February 1, 1993
Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aortaB Tesfamariam, J J Palacino, R M Weisbrod, et al.
The American Journal of Physiology|October 1, 1993
Reduced Na(+)-K+ pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibitionB Tesfamariam, S Gupta, P J Oates, et al.
Nature|June 12, 1998
A one-million-year-old Homo cranium from the Danakil (Afar) Depression of EritreaE Abbate, A Albianelli, A Azzaroli, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformationsW N Washburn, T W Harper, G Wu, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
Influence of the endothelium on tone and the response of isolated pig coronary artery to norepinephrineR A Cohen, K M Zitnay, R M Weisbrod, et al.
Journal of Cardiovascular Pharmacology|February 1, 1993
Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aortaB Tesfamariam, J J Palacino, R M Weisbrod, et al.
The American Journal of Physiology|October 1, 1993
Reduced Na(+)-K+ pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibitionB Tesfamariam, S Gupta, P J Oates, et al.
Nature|June 12, 1998
A one-million-year-old Homo cranium from the Danakil (Afar) Depression of EritreaE Abbate, A Albianelli, A Azzaroli, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformationsW N Washburn, T W Harper, G Wu, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 4